PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$22.33
-0.31 (-1.37%)
Open$22.76
Previous Close$22.64
Day High$22.95
Day Low$22.19
52W High$27.64
52W Low$18.80
Volume—
Avg Volume443.6K
Market Cap878.35M
P/E Ratio170.95
EPS$0.13
SectorPharmaceuticals
Analyst Ratings
Buy
13 analysts
Price Target
+1.7% upside
Current
$22.33
$22.33
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 616.16M | 598.79M | 216.59M |
| Net Income | 5.97M | 5.22M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 54.71M | 50.51M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |